Comments

Biomea Fusion Stock Price, Quotes and Forecasts

Q: What sector and industry does Biomea Fusion (BMEA) operate in?

Biomea Fusion is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

BMEANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Biomea Fusion (BMEA) Forecast

News Earnings Biomea Fusion (BMEA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Biomea Fusion Stock Price, Quotes and Forecasts | NASDAQ:BMEA | Benzinga

Explore Biomea Fusion stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BMEA.

Open	$1.94
Close	-
Volume / Avg.	1.83M / 2.09M
Day Range	$1.79 - $1.95
52 Wk Range	1.29 - 13.07
Market Cap	$65.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	46.57%
Days to Cover	16.25

Recent News

Crude Oil Moves Higher; US Weekly Jobless Claims Decline

Avi Kapoor

US Stocks Likely To Open Higher Despite Trump's 'Unconditional Surrender' Call: All Eyes On Powell As Experts Predict Inflation Will Limit Fed's Rate Cut Capacity

U.S. futures were higher on Wednesday as oil futures tumbled after Donald Trump called for an "Unconditional Surrender" by Iran late Tuesday.

Rishabh Mishra

Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.94
Close	-
Volume / Avg.	1.83M / 2.09M
Day Range	$1.79 - $1.95
52 Wk Range	1.29 - 13.07
Market Cap	$65.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	46.57%
Days to Cover	16.25

About Biomea Fusion Inc

Sector

Health Care

Industry

Biotechnology

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discover...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Biomea Fusion (BMEA) stock?

You can purchase shares of Biomea Fusion (NASDAQ:BMEA) through any online brokerage.

View our list of the best stock brokerages

Who are Biomea Fusion (BMEA) competitors?

Other companies in Biomea Fusion’s space includes: Zura Bio (NASDAQ:ZURA), Outlook Therapeutics (NASDAQ:OTLK), Skye Bioscience (NASDAQ:SKYE), Armata Pharmaceuticals (AMEX:ARMP) and Inovio Pharmaceuticals (NASDAQ:INO).

What is the forecast, or price target, for Biomea Fusion (BMEA) stock?

Biomea Fusion has a consensus price target of $31.39.

What is the current price for Biomea Fusion (BMEA)?

The stock price for Biomea Fusion (NASDAQ: BMEA) is $1.8094 last updated June 20, 2025 at 1:37 PM EDT.

Does Biomea Fusion (BMEA) pay a dividend?

There are no upcoming dividends for Biomea Fusion.

When is Biomea Fusion (NASDAQ:BMEA) reporting earnings?

Biomea Fusion’s Q2 earnings are confirmed for Wednesday, July 30, 2025.

Is Biomea Fusion (BMEA) going to split?

There is no upcoming split for Biomea Fusion.

What sector and industry does Biomea Fusion (BMEA) operate in?

Biomea Fusion is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.